Media Highlights

Media Highlights

Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of Carcinoid Syndrome

March 12, 2024

Dr. Aman Chauhan, as an investigator in the study, is quoted discussing the “clinical improvements that paltusotine demonstrated for patients with carcinoid syndrome” and the hope that this treatment might bring for those with neuroendocrine tumors.

Read the Full article

Tags:   Aman Chauhan, Neuroendocrine, Sylvester Comprehensive Cancer Center